CECAD
CECAD is a publicly funded German Excellence Cluster at the University of Cologne investigating the molecular mechanisms of aging and age-related diseases. It serves early-career researchers, clinician scientists, and the European aging research community through 60+ Principal Investigators, eight shared core facilities, and a fully funded PhD graduate school.
- Company typePrivate
- Founded2008
- HeadquartersCologne, Germany
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What CECAD does
CECAD (Cologne Cluster of Excellence for Aging Research) is a publicly funded academic research cluster at the University of Cologne, established in 2008 under the German Excellence Strategy. It investigates the molecular and cellular mechanisms of aging and age-related diseases, with 60+ Principal Investigators spanning cell death, metabolism, mitochondrial biology, genomics, neuroscience, and translational medicine. The cluster serves early-career researchers, clinician scientists, and the broader European aging research community.
Its core operational layer consists of eight shared technology core facilities (Bioinformatics, FACS, Genomics, Imaging including electron microscopy, in vivo Research, Lipidomics/Metabolomics, Proteomics, and Systems Neuroscience), a Cologne Graduate School of Ageing Research (CGA) offering fully funded international PhD training, a translational research arm supporting interventional clinical trials and cohort studies, and a career development programme covering postdocs, group leaders, and clinician scientists. Its 'products' are therefore research output, trained scientists, and shared infrastructure rather than commercial goods.
The business model is non-commercial and grant-funded. DFG Excellence Cluster funding, channeled through the University of Cologne and the state of North Rhine-Westphalia, covers research operations, faculty positions, graduate fellowships, and core facilities. Supplementary revenue derives from competitive third-party grants (e.g., Plus 3, BMBF, EU) and partner contributions. There is no commercial pricing model, no product sales, and no equity structure; CECAD operates as a government-supported research organization within the public university system.
CECAD firmographics
Firmographics- Name
- CECAD
- Legal name
- Exzellenzcluster CECAD an der Universität zu Köln
- Website
- https://cecad.uni-koeln.de
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- CECAD is a publicly funded German Excellence Cluster at the University of Cologne investigating the molecular mechanisms of aging and age-related diseases. It serves early-career researchers, clinician scientists, and the European aging research community through 60+ Principal Investigators, eight shared core facilities, and a fully funded PhD graduate school.
- Ownership category
- akta.pro rank
CECAD industry classification
Industry- Product category
- Academic Biomedical Research
- NAICS
- Colleges, Universities, and Professional Schools (6113), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- akta.pro primary industry
- Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)
Keywords
Where CECAD is headquartered
LocationHeadquarters
- HQ city
- Cologne
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
CECAD business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations
Revenue model
- Government Research Funding: CECAD is funded as an Excellence Cluster by the German federal and state governments through the Deutsche Forschungsgemeinschaft (DFG) and the University of Cologne. This covers research operations, faculty positions, graduate school programs, and core facility operations.
- Graduate Fellowships: PhD students receive full fellowships for the duration of the doctoral programme, funded through the excellence cluster funding mechanism.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels8 records
CECAD product offering
Product offeringCore offering
CECAD operates as a university Cluster of Excellence conducting fundamental research on the biology of aging and aging-associated diseases. It delivers structured PhD training through the Cologne Graduate School of Ageing Research (CGA) with full fellowships, maintains state-of-the-art core research facilities (Bioinformatics, FACS, Genomics, Imaging, Lipidomics/Metabolomics, Proteomics, Systems Neuroscience, in vivo Research), and provides translational research infrastructure supporting clinical trials and cohort studies.
Product overview
CECAD (Cluster of Excellence for Aging Research) at the University of Cologne is a research excellence cluster focused on understanding the molecular mechanisms of ageing and age-related diseases. The organization offers a unified research ecosystem consisting of the Cologne Graduate School of Ageing Research (a PhD training program), Core Facilities (state-of-the-art research infrastructure including Bioinformatics, FACS, Genomics, Imaging, Lipidomics/Metabolomics, Proteomics, and Systems Neuroscience), Translational Research Infrastructure, and an Education & Career Programme. The research areas span from basic biological mechanisms to clinical applications, with over 60 Principal Investigators contributing to aging research.
Differentiator
Problem solved
Functional benefit
Brands
- Cologne Graduate School of Ageing Research (CGA): The graduate school component of CECAD offering structured PhD training in biomedical disciplines within an international environment, focusing on molecular mechanisms underlying ageing and age-related diseases.
Products and services
- Cologne Graduate School of Ageing Research (CGA) Structured PhD training programme in biomedical disciplines focused on understanding the molecular mechanisms of ageing and age-related diseases, with internationally recognized principal investigators and all courses delivered in English.
- Core Facilities State-of-the-art research technology platforms including Bioinformatics, FACS, Genomics, Imaging (light and electron microscopy), Lipidomics/Metabolomics, Proteomics, Systems Neuroscience, and in vivo Research facilities, available to internal and external researchers.
- Translational Research Infrastructure Infrastructure supporting the translation of basic aging research into clinical applications, including interventional clinical trials, translational cohort projects, and the TSAR Online Course for training researchers in translational methodologies.
- Education & Career Programme Career development offerings including workshops, travel grants, graduate symposia, PhD/Postdoc retreats, Open Tuesdays mentorship program, peer mentoring, and specialized training tracks for medical students and clinician scientists.
Quantifiable outcome
- Full fellowships provided to all PhD students for duration of programme
- +1 more outcomes
Companies that use CECAD
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
CECAD technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
CECAD partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core, major and minor.
- University of ColognecoreUniversity of Cologne is the host institution for CECAD Cluster of Excellence. The University provides institutional support, infrastructure, faculty appointments, and administrative services. CECAD operates as a strategic research initiative within the University's research framework.
- German Center for Neurodegenerative Diseases (DZNE)coreDZNE is a partner institution shown in the CECAD network, collaborating on neurodegenerative disease research relevant to aging. The partnership provides access to complementary research infrastructure and expertise.
- University Hospital of ColognecoreUniversity Hospital Cologne partners with CECAD to support translational research efforts, bridging basic aging research with clinical applications and patient care.
- Max Planck Institute for Biology of AgeingcoreThe Max Planck Institute for Biology of Ageing in Cologne collaborates with CECAD on aging research, combining expertise in the biology of aging with CECAD's broader research infrastructure.
- Max Planck Institute for Metabolism ResearchcoreThe Max Planck Institute for Metabolism Research partners with CECAD on research at the intersection of metabolism and aging, providing complementary scientific expertise.
- Wissenschaftsrat (German Science Council)majorThe Wissenschaftsrat provides strategic evaluation and recommendations for German research institutions including excellence clusters, contributing to strategic positioning.
- Körber FoundationminorKörber Foundation hosts CECAD speakers (e.g., Prof. Björn Schumacher) for public lectures on healthy aging, supporting science communication and public outreach.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
CECAD competitors and assessment
Company assessmentDirect peers
- Mayo Clinic Robert and Arlene Kogod Center on Aging: Major US aging research center embedded in a leading academic medical center, with strong translational and clinical research programs on age-related disease. Directly comparable as a clinical-translational aging research hub with similar academic-medical-center structure to CECAD's University Hospital Cologne partnership.
- Buck Institute for Research on Aging: The first independent research institute in the US focused solely on aging, with a large multi-PI research portfolio spanning geroscience, neurodegeneration, and age-related disease. Directly comparable in mission, scale, and translational orientation, though with stronger US-based philanthropic and industry ties.
- Max Planck Institute for Biology of Ageing: Co-located in Cologne and a core CECAD partner, the Max Planck Institute for Biology of Ageing pursues the same fundamental biology of aging research with complementary expertise. It is the most directly comparable peer given the shared city, shared scientific focus, and overlapping PI networks.
- Karolinska Institutet - Aging Research Center: Sweden's premier medical university hosts significant aging research programs across epidemiology, molecular biology, and clinical geriatrics. Directly comparable as a leading European academic institution with multi-disciplinary aging research and international recruitment.
- Albert Einstein College of Medicine - Institute for Aging Research: Major US aging research institute at an academic medical center in New York, conducting fundamental and translational research on the biology of aging and age-related disease. Directly comparable in scientific scope, institutional setting, and translational mission.
- University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging: One of the NIA-funded Nathan Shock Centers in the US, conducting basic biology of aging research with strong core facility infrastructure. Directly comparable in scientific focus, core facility model, and translational training mission.
- Leibniz Institute on Aging - Fritz Lipmann Institute (FLI): Germany's other premier aging research institute, located in Jena, conducting molecular and cellular biology of aging research with similar DFG and state-government funding structures. Directly comparable in scientific scope, funding model, and translational orientation.
Others
- Glenn Foundation for Medical Research: Private foundation that funds aging research programs and investigators at major US academic institutions. Comparable as a major funder in the aging biology ecosystem and potential partnership or co-funding counterpart for CECAD's research programs.
- American Federation for Aging Research (AFAR): Leading US non-profit organization supporting aging research through grants, training programs, and scientific conferences. Comparable as a coordinating body and funder in the aging research ecosystem, relevant for understanding funding flows and partnership opportunities.
Emerging players
- Okinawa Institute of Science and Technology (OIST): Japanese interdisciplinary graduate university with an emerging aging and longevity research program, international English-language environment, and government funding. Comparable in graduate training model and English-language international recruitment, though aging research is a smaller portion of its overall portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
CECAD social profiles
Digital presenceCECAD financial estimates
Financial estimateRevenue estimate
Valuation estimate
CECAD leadership team
Management profileNumber of profiles
Profiles4 records
CECAD funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CECAD M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CECAD
What does CECAD do?
CECAD operates as a university Cluster of Excellence conducting fundamental research on the biology of aging and aging-associated diseases. It delivers structured PhD training through the Cologne Graduate School of Ageing Research (CGA) with full fellowships, maintains state-of-the-art core research facilities (Bioinformatics, FACS, Genomics, Imaging, Lipidomics/Metabolomics, Proteomics, Systems Neuroscience, in vivo Research), and provides translational research infrastructure supporting clinical trials and cohort studies.
Is CECAD a public or private company?
CECAD is a private company. It is classified as state government owned and is currently operating.
When was CECAD founded?
CECAD was founded in 2008. It employs 501 to 1,000 people.
Where is CECAD based?
CECAD is headquartered in Cologne, Germany, in the Europe region.
How does CECAD make money?
Two revenue lines are on record. Government Research Funding is the primary driver. The others are graduate Fellowships.
Who are CECAD's main competitors?
Direct peers on record are Mayo Clinic Robert and Arlene Kogod Center on Aging, Buck Institute for Research on Aging, Max Planck Institute for Biology of Ageing, Karolinska Institutet - Aging Research Center, Albert Einstein College of Medicine - Institute for Aging Research, University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging and Leibniz Institute on Aging - Fritz Lipmann Institute (FLI). Others are Glenn Foundation for Medical Research and American Federation for Aging Research (AFAR). Okinawa Institute of Science and Technology (OIST) is listed as an emerging player.
Does CECAD have an API?
No public API is recorded for CECAD.
What industry is CECAD in?
CECAD's product category is Academic Biomedical Research. Its primary akta.pro industry code is EDAHAAAC, Public Research Universities with Academic Medical Centers (AMCs). Its NAICS code is 6113.